People / Staff

Susana Rives Solà

Search publications

Publications

  • Vega-García N, Benito R, Esperanza-Cebollada E, Llop M, Robledo C, Vicente-Garces C, Alonso J, Barragán E, Fernandez-Isern G, Hernández-Sánchez JM, Martín-Izquierdo M, Maynou-Fernández J, Minguela A, Montaño A, Ortega M, Torrebadell-Burriel M, Cervera J, Sánchez J, Jiménez-Velasco A, Riesco S, Hernández-Rivas JM, Lassaletta Á, Fernández JM, Rives-Solà S, Dapena JL, Ramírez M and Camós-Guijosa M.

    Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia

    Journal of Personalized Medicine . 10(4): 244. Number of citations: 1

    [doi:10.3390/jpm10040244]

  • Fuster JL, Molinos-Quintana A, Fuentes C, Fernández JM, Velasco P, Pascual T, Rives-Solà S, Dapena JL, Sisinni L, López-Godino O, Palomo P, Villa-Alcázar M, Bautista F, González-Vicent M, López-Duarte M, García-Morín M, Ramos-Elbal E and Ramírez M.

    Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP)

    BRITISH JOURNAL OF HAEMATOLOGY . 190(5): 764-771. Number of citations: 19

    [doi:10.1111/bjh.16647]

  • Mirones I, Moreno L, Patiño-García A, Lizeaga G, Moraleda JM, Toribio ML and Pérez-Martínez A.

    Inmunoterapia con células CAR-T en hematooncología pediátrica.

    ANALES DE PEDIATRIA . 93(1): . Number of citations: 1

    [doi:10.1016/j.anpedi.2019.12.014]

  • Hrusak O, Kalina T, Wolf J, Balduzzi A, Provenzi M, Rizzari C, Rives-Solà S, Del Pozo Carlavilla M, Alonso MEV, Domínguez-Pinilla N, Bourquin JP, Schmiegelow K, Attarbaschi A, Grillner P, Mellgren K, van der Werff Ten Bosch J, Pieters R, Brozou T, Borkhardt A, Escherich G, Lauten M, Stanulla M, Smith O, Yeoh AEJ, Elitzur S, Vora A, Li CK, Ariffin H, Kolenova A, Dallapozza L, Farah R, Lazic J, Manabe A, Styczynski J, Kovacs G, Ottoffy G, Felice MS, Buldini B, Conter V, Stary J and Schrappe M.

    Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment

    EUROPEAN JOURNAL OF CANCER . 132: 11-16. Number of citations: 121

    [doi:10.1016/j.ejca.2020.03.021]

  • Castella M, Caballero-Baños M, Ortiz-Maldonado V, González-Navarro EA, Suñé G, Antoñana-Vidósola A, Boronat A, Marzal B, Millán L, Martín-Antonio B, Jordi Cid Colom, Lozano M, García E, Tabera J, Trias E, Perpiña U, Canals JM, Baumann T, Benítez-Ribas D, ELENA CAMPO, Yagüe-Ribes J, Urbano-Ispizua Á, Rives-Solà S, Delgado J and Juan-Otero M.

    Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial

    FRONTIERS IN IMMUNOLOGY . 11: 482-482. Number of citations: 73

    [doi:10.3389/fimmu.2020.00482]

  • Laetsch TW, Myers GD, Baruchel A, Dietz AC, Pulsipher MA, Bittencourt H, Buechner J, De Moerloose B, Davis KL, Nemecek E, Driscoll T, Mechinaud F, Boissel N, Rives-Solà S, Bader P, Peters C, Sabnis HS, Grupp SA, Yanik GA, Hiramatsu H, Stefanski HE, Rasouliyan L, Yi L, Shah S, Zhang J and Harris AC.

    Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial

    LANCET ONCOLOGY . 20(12): 1710-1718. Number of citations: 51

    [doi:10.1016/S1470-2045(19)30493-0]

  • Bautista F, Cañete A, Ramírez-Villar GL, Fernández JM, Fuster JL, Diaz de Heredia C, Astigarraga I, García-Ariza M, Rives-Solà S, Dapena JL, Márquez C, Molinés A, Bermúdez MDM, Gallego S, Andrés MDM, Verdu-Amoros J, Hernández C, López M, Català-Temprano A, Lassaletta Á, Cruz-Martínez O, Ramírez M, Lendínez F, Carboné A, Gomez Sirvent J, Tallón M, Acha T, Moreno L, Fernández-Teijeiro A and Sociedad Española de Hematología y Oncología Pediátrica (SEHOP).

    ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in Spain

    CLINICAL & TRANSLATIONAL ONCOLOGY . 21(12): 1763-1770. Number of citations: 3

    [doi:10.1007/s12094-019-02221-9]

  • Castella M, Boronat A, Martín-Ibáñez R, Rodríguez V, Suñé G, Caballero M, Marzal B, Pérez-Amill L, Martín-Antonio B, Castaño J, Bueno C, Balagué O, González-Navarro EA, Serra-Pages C, Engel P, Vilella R, Benitez-Ribas D, Ortiz-Maldonado V, Jordi Cid Colom, Tabera J, Canals JM, Lozano M, Baumann T, Vilarrodona A, Trias E, ELENA CAMPO, Menendez P, Urbano-Ispizua Á, Yagüe-Ribes J, Pérez-Galán P, Rives-Solà S, Delgado J and Juan M.

    Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions.

    Molecular Therapy-Methods & Clinical Development . 12: 134-144. Number of citations: 59

    [doi:10.1016/j.omtm.2018.11.010]

  • Vega-García N, Malatesta R, Estella-Aguado MC, Pérez-Jaume S, Esperanza-Cebollada E, Torrebadell-Burriel M, Català-Temprano A, Gassiot S, Berrueco R, Ruiz-Llobet A, Alonso-Saladrigues A, Mesegue-Meda M, Pont-Martí S, Rives-Solà S and Camós-Guijosa M.

    Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases

    BRITISH JOURNAL OF HAEMATOLOGY . 182(4): 542-553. Number of citations: 7

    [doi:10.1111/bjh.15436]

  • Maude SL, Laetsch TW, Buechner J, Rives-Solà S, Boyer M, Bittencourt H, Bader P, Verneris MR, Stefanski HE, Myers GD, Qayed M, De Moerloose B, Hiramatsu H, Schlis K, Davis KL, Martin PL, Nemecek ER, Yanik GA, Peters C, Baruchel A, Boissel N, Mechinaud F, Balduzzi A, Krueger J, June CH, Levine BL, Wood P, Taran T, Leung M, Mueller KT, Zhang Y, Sen K, Lebwohl D, Pulsipher MA and Grupp SA.

    Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

    NEW ENGLAND JOURNAL OF MEDICINE . 378(5): 439-448. Number of citations: 3194

    [doi:10.1056/NEJMoa1709866]